Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

271 results about "Action potential" patented technology

In physiology, an action potential occurs when the membrane potential of a specific cell location rapidly rises and falls: this depolarisation then causes adjacent locations to similarly depolarise. Action potentials occur in several types of animal cells, called excitable cells, which include neurons, muscle cells, endocrine cells, glomus cells, and in some plant cells.

Moisture-resistant electrocardiogramy monitor

Physiological monitoring can be provided through a lightweight wearable monitor that includes two components, a flexible extended wear electrode patch and a reusable monitor recorder that removably snaps into a receptacle on the electrode patch. The wearable monitor sits centrally on the patient's chest along the sternum oriented top-to-bottom. The placement of the wearable monitor in a location at the sternal midline, with its unique narrow “hourglass”-like shape, significantly improves the ability of the wearable monitor to cutaneously sense cardiac electrical potential signals, particularly the P-wave and the QRS interval signals indicating ventricular activity in the ECG waveforms. In particular, the ECG electrodes on the electrode patch are tailored to be positioned axially along the midline of the sternum for capturing action potential propagation in an orientation that corresponds to the aVF lead used in a conventional 12-lead ECG that is used to sense positive or upright P-waves.
Owner:BARDY DIAGNOSTICS INC

Simulation system for cardiac ablation regimen evaluation

ActiveCN119028528Aavoid instabilityHigh numerical precisionMedical simulationImage analysisMyocardial fiberThoracic cavity
The invention provides a simulation system for heart ablation scheme evaluation, and the system comprises an image obtaining module which is used for obtaining a plurality of thoracic cavity images; the three-dimensional grid reconstruction module is used for marking ablation points of the plurality of thoracic cavity images and obtaining a heart three-dimensional grid through a finite element method; the fiber rotation direction calculation module is used for calculating a myocardial fiber rotation direction according to the heart three-dimensional grid, and obtaining a direction vector of the myocardial fiber rotation direction corresponding to each grid point on the heart three-dimensional grid; the electrophysiological parameter simulation module is used for simulating the cardiac action potential excitation process according to the electrophysiological parameters, the geometric positions of the grid points and the fiber rotation directions corresponding to the grid points; and the dynamic simulation module is used for simulating the cardiac electric signal according to the cardiac action potential excitation process to obtain a dynamic simulation result. According to the method, the simulation result is more real through anisotropy introduced by the rotation direction of the fiber.
Owner:SHANGHAI SHIZHI HEALTH TECH CO LTD

Parameterizing techniques for sub-perception and paresthesia therapy

A system for closed-loop control of sub-perception spinal cord stimulation therapy is provided. The system includes an implantable pulse generator (IPG) with an evoked compound action potential (ECAP) recording module and accelerometer. A regression model maps accelerometer data to optimal stimulation parameters for consistent nerve activation. This enables closed-loop therapy in the sub-perception domain where ECAP features are not visually detectable. A clinician programmer applies the model and sub-perception dose to therapy programs deployed to the IPG. The model can be customized to each patient by collecting ECAP and accelerometer data. The mapping reconciles ECAP -based control between perception and sub-perception domains by supplementing unavailable ECAP data with accelerometer data. This improves stimulation therapies for patients receiving sub-perception and multi-sensor paresthesia treatments.
Owner:BOSTON SCI NEUROMODULATION CORP

Systems and methods for guiding spinal cord stimulation using evoked potentials

Methods and systems for spinal cord stimulation (SCS) are disclosed. The methods and systems involve the use of electrode leads implanted within the spine of a patient to record nerve responses induced by a stimulus. The disclosed neural responses differ in various aspects from the electrical responses previously measured in the SCS context, such as stimulation artifacts and evoked compound action potentials (ECAPs). The disclosed neural responses typically occur at a later time after inducing the stimulation pulse. Another significant feature is that when the frequency of evoked stimulation is ultra-low, such as about 10 Hz or less, the disclosed neural response is most significantly observed at a consistent, relatively constant amplitude as a whole. The disclosed methods and systems may use these neural responses as indications of pain, treatment, and / or another clinically relevant dimension to guide / confirm stimulation placement, as well as feedback control for stimulation parameters.
Owner:BOSTON SCI NEUROMODULATION CORP

Parameterizing techniques for sub-perception and paresthesia therapy

A system for closed-loop control of sub-perception spinal cord stimulation therapy is provided. The system includes an implantable pulse generator (IPG) with an evoked compound action potential (ECAP) recording module and accelerometer. A regression model maps accelerometer data to optimal stimulation parameters for consistent nerve activation. This enables closed-loop therapy in the sub-perception domain where ECAP features are not visually detectable. A clinician programmer applies the model and sub-perception dose to therapy programs deployed to the IPG. The model can be customized to each patient by collecting ECAP and accelerometer data. The mapping reconciles ECAP-based control between perception and sub-perception domains by supplementing unavailable ECAP data with accelerometer data. This improves stimulation therapies for patients receiving sub-perception and multi-sensor paresthesia treatments.
Owner:BOSTON SCI NEUROMODULATION CORP

Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy

The invention relates to the use of cannabidiol (CBD), at a dose of greater than 300 mg / day, in combination with a standard anti-epileptic drug (SAED) which acts via sodium or calcium channels, for use in the treatment of epilepsy. The SAED is preferably one which •modities low-threshold or transient neuronal calcium currents, or •reduces high-frequency neuronal firing and sodium-dependent action potentials and enhances GABA effects. Preferred SAEDs are ethosuximide and valproate.
Owner:JAZZ PHARMACEUTICALS OPERATIONS UK LTD

Dynamic pain nerve decoding and intervention system based on prefrontal lobe time sequence characteristic window

The invention relates to the technical field of medical health data information decoding analysis and processing, and particularly discloses a dynamic pain nerve decoding and intervention system based on a prefrontal lobe time sequence characteristic window, which comprises a signal acquisition module, a dynamic window control module, a phase prediction module, an intervention execution module and an event driving controller. The dynamic window control module intelligently adjusts the duration of a signal analysis window through real-time calculation of the energy ratio of a # imgabs 0 # frequency band to a # imgabs 1 # frequency band, and accurately locks a transient characteristic window in a pain outbreak period; the phase prediction module realizes millisecond-level synchronization of stimulation pulse and a rising edge of action potential of a neural cluster based on a two-factor mapping mechanism of an individualized conduction velocity level and an oscillation frequency; the event-driven controller reduces the power consumption to a wearable device level while maintaining 10 ms-level real-time response through a dynamic resource allocation strategy.
Owner:YIBIN PUAI GERIATRIC HOSPITAL CO LTD

Signal acquisition and nerve stimulation method based on wireless implantable brain-computer interface

The invention discloses a signal acquisition and nerve stimulation method based on a wireless implantable brain-computer interface, and the method comprises the steps: building communication connection with an upper computer, and obtaining a stimulation current parameter and a signal acquisition parameter set by the upper computer; generating bipolar stimulation current according to the stimulation current parameter, and performing brain wave stimulation processing on a target object according to the bipolar stimulation current; performing signal acquisition processing on the electroencephalogram signal after electroencephalogram stimulation processing according to the signal acquisition parameter to obtain a target electroencephalogram signal; performing action potential signal detection processing and fragmentation processing on the target electroencephalogram signal to obtain a target electroencephalogram data packet, and uploading the target electroencephalogram data packet to the upper computer. According to the invention, real-time electrical stimulation control and electroencephalogram data acquisition and return can be supported, and the real-time regulation and control of animal robot behaviors by researchers and the synchronization of electroencephalogram signal research can be effectively ensured.
Owner:SHENZHEN INST OF ADVANCED TECH CHINESE ACAD OF SCI

Closed-loop rTMS regulation and control system driven by biomarker

The invention provides a closed-loop rTMS regulation and control system driven by a biomarker. Relates to the technical field of closed-loop rTMS diagnosis and treatment. In the previous closed-loop rTMS intervention process, mostly evoked potentials, such as action potentials and local field potentials, which have limited representation degrees on autonomous motion functions are monitored; therefore, a closed-loop rTMS intervention system capable of dynamically monitoring spontaneous rhythmic oscillation PMBS with high representativeness on the upper limb movement function is established, the existing closed-loop rTMS intervention paradigm mostly depends on operation tasks, scales or EMG measurement and other means to evaluate the intervention curative effect, interaction between hemispheres represented by EEG is considered in the assessment of the upper limb movement rehabilitation capacity, and the intervention effect is improved. Therefore, the movement coordination of the upper limbs on the two sides is evaluated.
Owner:NORTHWEST NORMAL UNIVERSITY

Application of Van der Waals tellurium nano material as near-infrared IIa light nerve regulation material

The invention relates to the technical field of photoelectric materials, in particular to application of a Van der Waals tellurium nano material as a near-infrared IIa light nerve regulation material. The invention provides an application of a Van der Waals Te nanometer material as a near-infrared IIa light nerve regulation material, and a preparation method of the Van der Waals Te nanometer material comprises the following steps: taking selenium telluride as a raw material, carrying out chemical vapor deposition on the surface of a substrate, adjusting the temperature of the substrate to 200-400 DEG C, and carrying out heat preservation for 2-4 hours, so as to obtain the Van der Waals Te nanometer material. The Van der Waals tellurium nanometer material is obtained; the chemical vapor deposition is carried out under the condition of introducing nitrogen. The Van der Waals tellurium nano material has a wide spectrum (from visible light to near-infrared light) for optical nerve regulation, the wave band can reach the near-infrared IIa (1.3-1.4 microns) wave band, and under the irradiation of 1.31 microns of light of the near-infrared IIa, mouse cortical nerve cells can be successfully induced to generate action potential.
Owner:SHANGHAI INSTITUTE OF TECHNICAL PHYSICS CHINESE ACADEMY OF SCIENCES

Three-dimensional electric field coupling modeling method for analgesia

According to the three-dimensional electric field coupling modeling method for analgesia provided by the invention, the propagation process of an electric field in each physiological tissue is accurately simulated by constructing a multi-layer bionic tissue model, so that the accuracy and effect of analgesia treatment are improved; calculating the conductivity and dielectric constant of each layer of tissue, performing numerical simulation on electric field distribution by using a finite element analysis technology, optimizing electrode configuration and electrical stimulation parameters, and ensuring the uniformity and stability of the electric field of a target area; a neurophysiology model is integrated, the conduction law of nerve fiber action potential is dynamically simulated, the stimulation effect of electric field intensity on nerve fibers is quantitatively analyzed, analgesia parameters are further optimized, and accurate control over pain signal transmission is achieved. The problems that in an existing electrical stimulation technology, electric field distribution is not uniform, electrode contact is not stable, and the stimulation effect is difficult to last are effectively solved, wide clinical application prospects are achieved, and an efficient, stable and accurate solution is provided especially in non-invasive treatment of chronic pain.
Owner:THE FIRST AFFILIATED HOSPITAL OF NAVAL MEDICAL UNIVERSITY OF CHINESE PEOPLES LIBERATION ARMY

Feedback control of neuromodulation

An automated method of controlling neural stimulation. A neural stimulus is applied to a neural pathway in order to give rise to an evoked action potential on the neural pathway, and the stimulus is defined by at least one stimulus parameter. A neural compound action potential response evoked by the stimulus is measured. From the measured evoked response a feedback variable such as observed ECAP voltage (V) is derived. A feedback loop is completed by using the feedback variable to control the at least one stimulus parameter value for a future stimulus. The method adaptively compensates for changes in a gain of the feedback loop caused by electrode movement relative to the neural pathway. A compensating transfer function is applied to the feedback variable, the compensating transfer function being configured to compensate for both (i) a distance-dependent transfer function of stimulation, and (ii) a distance dependent transfer function of measurement which is distinct from (i).
Owner:SALUDA MEDICAL PTY LTD

Heart electrophysiology simulation system

The application provides a heart electrophysiology simulation system, comprising: an image acquisition module for acquiring a plurality of thoracic cavity images; the three-dimensional grid reconstruction module is used for obtaining a ventricle three-dimensional grid through a finite element method according to the plurality of thoracic cavity images; the ventricular conduction network construction module is used for generating a ventricular conduction network according to the ventricular three-dimensional grid, the ventricular conduction network comprises a plurality of first grid points, and the geometric position of each first grid point shares the point cloud of the ventricular three-dimensional grid; the electrophysiological parameter simulation module is used for simulating the conduction process of the heart action potential in the ventricle according to the geometric position of the first grid point and electrophysiological parameters, and the electrophysiological parameters comprise cell level parameters and tissue level parameters; and the dynamic simulation module is used for simulating the cardiac electric signal according to the conduction process of the cardiac action potential in the ventricle to obtain a dynamic simulation result.
Owner:SHANGHAI SHIZHI HEALTH TECH CO LTD

Systems and methods for targeting and dosing spinal cord stimulation

PCT designated stage expiredWO2025038713A1Spinal electrodesExternal electrodesPhysical therapyLumbar
Methods and systems for performing spinal cord stimulation in the cervical spine while sensing for an evoked response, such as an evoked synaptic action potential (ESAP) at a different location from the location of stimulation. A first lead may be positioned in the cervical spine for issuing therapy pulses, and sensing is performed at a thoracic or lumbar location, or a caudal cervical location relative to the location of stimulation. First and second leads may be used in a single system, or two separate systems, one for stimulation and another for sensing, may be used.
Owner:BOSTON SCI NEUROMODULATION CORP

Application of Cpeb3 gene inhibitor and copper death inhibitor in preparation of medicine for treating myocardial ischemia-reperfusion injury

The invention discloses application of a Cpeb3 gene inhibitor and a copper death inhibitor in preparation of a medicine for treating myocardial ischemia-reperfusion injury, and relates to the technical field of myocardial ischemia-reperfusion injury. By specifically reducing or knocking out Cpeb3 expression, myocardial repair can be remarkably promoted, action potential stability is improved, and the death rate is reduced. Therefore, Cpeb3 is a specific intervention target spot of copper death in Gpc6 + CMs. The small molecule inhibitor of Cpeb3 can remarkably reverse changes of copper death, aerobic respiration and / or glycolysis caused by Cpeb3 activation. In addition, the copper death inhibitor can improve the survival rate of myocardial cells, reverse the change of aerobic respiration and / or glycolysis induced by Cu, and reverse the change of glycolysis, pentose phosphate pathway and tricarboxylic acid cycle metabolites caused by Cu stimulation. Therefore, the invention provides a new solution for prevention and treatment of myocardial ischemia reperfusion injury, and has a good application prospect.
Owner:SICHUAN ACADEMY OF MEDICAL SCI SICHUAN PROVINCIAL PEOPLES HOSPITAL

Systems and methods for evaluating spinal cord stimulation therapy

A method of evaluating spinal cord stimulation (SCS), comprising obtaining neural response data generated by a spinal cord stimulator, where the neural response data describes one or more neural signals evoked in the spinal cord of a patient by applying diagnostic stimuli. One or more evoked compound action potentials (ECAPs) associated with the respective one or more neural signals are detected. The one or more detected ECAPs are processed to generate one or more evaluation metrics, and the one or more evaluation metrics are used to generate a confidence score indicating a degree of effectiveness of SCS on the patient.
Owner:SALUDA MEDICAL PTY LTD

Systems, devices, components and methods for detecting the locations of sources of cardiac rhythm disorders in a patient's heart using improved electrographic flow (EGF) methods

ActiveUS12220199B2Surgical navigation systemsCatheterDiseaseIntracardiac electrode
Disclosed are various examples and embodiments of systems, devices, components and methods configured to estimate the action potential wave propagation in a patient's heart, and subsequently to detect at least one location or type of at least one source of, or rotational phenomenon associated with, at least one cardiac rhythm disorder using intracardiac electrodes and a modified multi-frame Horn-Schunck algorithm to generate a map corresponding to a spatial map, the map being configured to reveal on a monitor or display to a user the at least one location of the at least one source of the at least one cardiac rhythm disorder.
Owner:BOSTON SCIENTIFIC SCIMED INC

Monitoring diaphragmatic response to phrenic nerve stimulation

ActiveUS20250235254A1ElectrotherapyCatheterEcg signalMuscle action potential
The disclosure relates to a computer-implemented method for monitoring diaphragmatic response to phrenic nerve stimulation. The method comprises receiving in real-time a diaphragmatic CMAP signal. The method comprises computing a baseline value of a characteristic of the CMAP signal. The characteristic represents a diaphragmatic response intensity to a phrenic nerve stimulation. The method comprises determining a threshold value of the characteristic, representing a boundary of values of the characteristic indicative of upcoming diaphragmatic palsy. The determining of the threshold value includes shifting the baseline value. The method comprises receiving in real-time a ECG signal. The method comprises repeating in real-time: detecting a QRS complex in the ECG signal, monitoring the CMAP signal, computing a real-time value of the characteristic, comparing the real-time value to the threshold value, and outputting an alert when the threshold is passed. The real-time value of the characteristic is asynchronous to the QRS complex.
Owner:CIRCLE SAFE

Self-adaptive functional electrical stimulation system based on bimodal feedback and control method

The invention relates to the technical field of medical rehabilitation treatment, and discloses a self-adaptive functional electrical stimulation system based on bimodal feedback and a control method. The system comprises a main control module, a stimulation output module, an electroneurographic signal detection module, a biological impedance test module and a safety isolation module. The main control module comprises a safety current determination unit, a stimulation control unit and a dynamic calibration unit which are respectively used for determining an individualized initial safety current based on neural action potential feedback, controlling treatment stimulation output and dynamically calibrating a safety current upper limit according to biological impedance change before and after stimulation. According to the invention, through bimodal feedback of electroneurographic signals and biological impedance, individualized calibration and real-time dynamic optimization of stimulation parameters are realized, and the problem that the treatment effect and safety are difficult to guarantee due to the fact that traditional functional electrical stimulation depends on experience setting and lacks physiological feedback is solved; and the accuracy, safety and adaptability of rehabilitation treatment are remarkably improved.
Owner:UNIV FOR SCI & TECH ZHENGZHOU

Selective stimulation of peripheral nerves

Methods and systems for providing peripheral nerve stimulation are disclosed. Stimulation is delivered to a trunk of the nerve using electrodes configured at different circumferential locations about the nerve. Action potentials evoked by the stimulation within branches of the nerve are measured to map neural element within the trunk to the branches. The mapping can inform the selection of stimulation parameters that provide a therapeutic benefit and / or avoid unwanted side effects.
Owner:BOSTON SCI NEUROMODULATION CORP

Pulsed electric field energy delivery timing optimization

PendingUS20260137438A1ElectrotherapyDiagnosticsCardiac cycleFibrillation
Devices, systems and methods are provided for treating target tissue with pulsed electric field energy in a manner that does not induce cardiac arrhythmias such as fibrillation of the heart and therefore negates any need for cardiac synchronization of energy delivery. Cardiac synchronization is typically employed to avoid delivering energy during portions of the cardiac cycle that are vulnerable to inducing fibrillation. Thus, herein parameters are manipulated to reduce the probability of inducing an arrhythmia. Typically, high voltage energy can trigger a premature action potential within the cardiac muscle as the delivered energy increases the cardiac muscle cell membrane permeability allowing ion transport, which can induce cardiac arrhythmias, especially ventricular fibrillation. However, both shorter pulse durations (i.e. higher frequencies such as 100-600 kHz) and biphasic waveform shapes theoretically and practically reduce the probability of inducing an arrhythmia.
Owner:GALVANIZE THERAPEUTICS INC

Targeted physiotherapy instrument based on unipolar electricity and targeted adjustment method thereof

The invention discloses a target physiotherapy instrument based on unipolar electricity and a target adjusting method thereof, and the target physiotherapy instrument comprises a physical sign detection bracelet which is used for detecting the heartbeat and body temperature of a human body and transmitting the heartbeat and body temperature to a host, and the host adjusts the parameters of a required electric field according to the heartbeat and body temperature changes; the power adjusting circuit controls the space electric field generator to output an electric field with corresponding electric field intensity according to the parameters of the required electric field; the frequency adjusting circuit is used for controlling the duration and the frequency of action potential periods in different periods according to the cell types of different targeted parts; and the space electric field generator comprises an electric field emission unit and a booster circuit connected with the frequency regulation circuit, and the electric field emission unit outputs to a targeted part according to regulation and control of the power regulation circuit and the frequency regulation circuit to form a monopolar space electric field. By monitoring the temperature and heartbeat changes of the human body in real time, parameters are automatically adjusted and adjusted, and the method has the advantages of being high in adjusting speed and high in precision.
Owner:GUANGZHOU AIYIN ELECTRONICS CO LTD

Devices and methods for delivery of electrical current for pain relief

Device / system that provides pain relief by delivering stimulation that neither generates action potentials nor completely blocks neural transmission (in the peripheral nerve). The present teachings provide relief by modulating release of neurotransmitters in peripheral nerves to cause neuromodulation at the level of the peripheral nerve (modulation of neural signals in the peripheral nerve). The present teachings provide relief by modulating release of neurotransmitters in peripheral nerves to cause neuromodulation at the level of the peripheral nerve (modulation of neural signals in the peripheral nerve) to alter the frequency of physiologically generated neural transmission.
Owner:SPR THERAPEUTICS

Device capable of simultaneously measuring myocardial specific contractility and action potential

PendingCN121844038ABioreactor/fermenter combinationsBiological substance pretreatmentsContractilityCardiac muscle tissue
The present invention addresses the problem of providing a device for simultaneously measuring an electrical signal and a contractile force using a highly mature cardiac muscle tissue having a 3D / oriented structure close to a cardiac muscle structure in a living body. As a solution, provided is a device for measuring the contractility of a cardiac muscle tissue, which is provided with a contractile part that includes a rod-like artificial cardiac muscle tissue that has a three-dimensional structure and in which cardiac muscle cells are oriented in the longitudinal direction, and which is used to measure the contractility of the contractile part.
Owner:ENKI TISSUE DESIGN CO LTD +1

Application of a polyketone compound with a special cage structure

ActiveCN119074715BOrganic active ingredientsNervous disorderDiseaseAction potential firing
The present invention relates to the technical field of microbial pharmaceutical chemistry, specifically to a method for preparing a Penicillium fungus ( Penicillium daleae The present invention relates to the medical use of a polyketide compound with a unique cage-like structure isolated from the fermentation product of a strain of the bacterium Mycobacterium spp. Using patch-clamp techniques to measure the action potential discharge frequency and spontaneous excitatory post-synaptic currents (sEPSCs) of hippocampal basket cells, the present invention confirmed that the compound has significant inhibitory activity on neuronal excitability and is non-toxic to N2a neurons at active concentrations. The compound can be used to prepare new drugs for treating diseases associated with neuronal hyperexcitability.
Owner:SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES

Intra-luminal medical device with evoked biopotential sensing capability

Sensing an evoked response to electrical stimulation of target tissue of a patient in conjunction with an intra-luminal electrode. The intra-luminal electrode may be implanted in a blood vessel or similar lumen proximal to the target tissue and the sensed signals and / or delivered stimulation may pass through the blood vessel. or other lumen, walls. In some examples the evoked response may be an evoked compound action potential (ECAP), which may also be evoked resonant neural activity (ERNA). The electrical stimulation may elicit a measurable response indicative of a thought pattern or neural state that would otherwise be undetectable using a non-evoked biopotential.
Owner:MEDTRONIC INC

Assessing neural state from action potentials

The neural health or state of a subject is assessed. A recording is obtained of a compound action potential arising in neural tissue of the subject. The recording is processed to determine whether a profile of the recorded compound action potential is anomalous, such as by exhibiting doublets, peak broadening or deformation, or other anomaly. An indication is output regarding the neural state of the subject based on determined anomalies in the recorded compound action potential.
Owner:SALUDA MEDICAL PTY LTD